{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "bioanalysis",
      "laboratory"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34806409",
  "DateCompleted": {
    "Year": "2021",
    "Month": "12",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "12",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.4155/bio-2021-0243"
    ],
    "Journal": {
      "ISSN": "1757-6199",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "24",
        "PubDate": {
          "Year": "2021",
          "Month": "Dec"
        }
      },
      "Title": "Bioanalysis",
      "ISOAbbreviation": "Bioanalysis"
    },
    "ArticleTitle": "Special Focus Issue - COVID-19: bioanalytical considerations, contributions and lessons - part 2.",
    "Pagination": {
      "StartPage": "1779",
      "EndPage": "1780",
      "MedlinePgn": "1779-1780"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-1298-7135"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "BioAgilytix, Germany."
          }
        ],
        "LastName": "Briscoe",
        "ForeName": "Chad J",
        "Initials": "CJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "F. Hoffmann-La Roche Ltd, Basel, Switzerland."
          }
        ],
        "LastName": "Barfield",
        "ForeName": "Matthew",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Bioanalysis",
    "NlmUniqueID": "101512484",
    "ISSNLinking": "1757-6180"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Monoclonal"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "biosynthesis"
      ],
      "DescriptorName": "Antibodies, Monoclonal"
    },
    {
      "QualifierName": [
        "biosynthesis"
      ],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "diagnosis",
        "therapy",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "instrumentation",
        "methods",
        "standards"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "organization & administration"
      ],
      "DescriptorName": "Point-of-Care Testing"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}